QinetiQ Group plc (LSE:QQ.), the defence technology and testing group, has stepped up its Capital return programme, appointing a broker on 28 September to execute a fourth £50m Tranche of its share buyback. The move keeps the FTSE 250 company active in the market as it heads towards interim results on 12 November 2026, and comes against a backdrop of solid defence spending in Europe that has not been fully reflected in QinetiQ's own share price this year.
Buyback programme continues
The new tranche is part of a £200m extension announced in March 2025 and designed to be executed over two years. The third £50m tranche was completed in September, and purchases under the fourth tranche will run until no later than 31 March 2027. Repurchased shares will be cancelled, reducing the share count, and the company noted that up to 49.6 million further shares can be bought under the authority granted at July's AGM.
Regular weekly notices, most recently on 6 October, confirm the programme is active. Separately, chief executive Steve Wadey received 220,495 shares on 30 September from a long-term incentive award granted in 2023, selling 103,945 at around 486.6p to cover tax and retaining the balance, subject to a two-year holding period.
Guidance held after first quarter
In July, QinetiQ said trading in the first quarter of its 2027 financial year, to 30 June 2026, was in line with expectations, supported by higher Revenue and a solid order backlog. It maintained guidance for revenue growth of 3% to 5%, an underlying Operating Margin of 11.0% to 11.5%, and Earnings Per Share growth of 8% to 10%. The company expects the first half to account for around 46% of full-year revenue, with an operating margin of about 11%.
The group's order backlog, cited at around £5bn in its earlier update, gives multi-year visibility, much of it from long-term contracts with the UK Ministry of Defence, including its test and evaluation work.
Share price and sector context
Despite steady guidance, QinetiQ's share price has been weaker than many defence peers. The shares traded at around 444p following the July update, down from levels above 520p seen during the previous financial year, and director dealing prices in late September suggest they remain below 490p. The company had earlier described near-term trading in some of its core markets as challenging, while stressing that it remained well positioned, with a book-to-bill ratio above one and a qualified pipeline of opportunities that it put at around £11bn. That combination of a large pipeline but uncertain conversion timing appears to have weighed on market sentiment through the year.
European governments, including the UK, have committed to increase defence budgets substantially, which has supported share prices across the sector. However, the timing of contract awards from the UK's Strategic Defence Review and wider spending plans remains a key uncertainty for suppliers. Interest rates are a secondary factor; the Bank of England held Bank Rate at 3.75% in September.
The interim results in November will be the next major catalyst. Investors will look for evidence of order intake, margin progression towards guidance, any update on US operations and how the buyback is affecting earnings per share. Cash generation will also be watched closely, given the company's policy of returning surplus capital through dividends and repurchases.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...